About Cation channel sperm-associated protein 3
Cation channel sperm-associated protein 3 (CATSPER3) is a protein
from Homo sapiens identified by UniProt accession
Q86XQ3, 398 residues long.
MolForge cross-references it against 0 known binders and
134 disease associations.
Target properties
| Protein name | Cation channel sperm-associated protein 3 |
| UniProt accession | Q86XQ3 |
| Gene | CATSPER3 |
| Organism | Homo sapiens |
| Length | 398 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Approved drugs hitting this target (4)
DrugCentral-linked approved drugs that act on this protein.
Disease associations (134)
Diseases linked to this target (Open Targets).
- bone density · score 0.41
- urate measurement · score 0.39
- body height · score 0.33
- cutaneous melanoma · score 0.25
- lung adenocarcinoma · score 0.23
- BMI-adjusted hip circumference · score 0.23
- heel bone mineral density · score 0.20
- breast adenocarcinoma · score 0.16
- squamous cell lung carcinoma · score 0.15
- eosinophil count · score 0.15
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q86XQ3-F1 | alphafold | PREDICTED | 79.95 | — |
Amino-acid sequence (398 residues)
MSQHRHQRHS RVISSSPVDT TSVGFCPTFK KFKRNDDECR AFVKRVIMSR FFKIIMISTV TSNAFFMALW TSYDIRYRLF RLLEFSEIFF VSICTSELSM KVYVDPINYW KNGYNLLDVI IIIVMFLPYA LRQLMGKQFT YLYIADGMQS LRILKLIGYS QGIRTLITAV GQTVYTVASV LLLLFLLMYI FAILGFCLFG SPDNGDHDNW GNLAAAFFTL FSLATVDGWT DLQKQLDNRE FALSRAFTII FILLASFIFL NMFVGVMIMH TEDSIRKFER ELMLEQQEML MGEKQVILQR QQEEISRLMH IQKNADCTSF SELVENFKKT LSHTDPMVLD DFGTSLPFID IYFSTLDYQD TTVHKLQELY YEIVHVLSLM LEDLPQEKPQ SLEKVDEK
Explore Cation channel sperm-associated protein 3 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets